Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
10/13/1994 | WO1994022908A1 Phosphonomethyldipeptides |
10/13/1994 | WO1994022907A1 New urea derivates, their preparation and their use |
10/13/1994 | WO1994022906A1 Inhibitors of endothelin converting enzyme |
10/13/1994 | WO1994022905A1 Purification of factor vii |
10/13/1994 | WO1994022901A1 Epidermal growth factor inhibitor |
10/13/1994 | WO1994022499A1 Systemic effects of nitric oxide inhalation |
10/13/1994 | WO1994022494A1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
10/13/1994 | WO1994022493A1 Chelators of type xn1s1x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses |
10/13/1994 | WO1994022492A1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use |
10/13/1994 | WO1994022491A1 Bifunctional chelators and their use in radiopharmaceuticals |
10/13/1994 | WO1994022490A1 Conjugates of proteins and bifunctional ligands |
10/13/1994 | WO1994022489A1 Hybrid genes for use in the production of th-independent cytotoxic t cells |
10/13/1994 | WO1994022483A2 Prodrugs with enhanced penetration into cells |
10/13/1994 | WO1994022482A1 Compositions including heme-containing proteins and methods relating thereto |
10/13/1994 | WO1994022479A1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
10/13/1994 | WO1994022478A1 PREVENTION OF TUMORS WITH MONOCLONAL ANTIBODIES AGAINST $i(NEU) |
10/13/1994 | WO1994022477A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
10/13/1994 | WO1994022475A1 Cloned leptospira outer membrane protein |
10/13/1994 | WO1994022473A1 Use of interleukin 7 to improve vaccine potency |
10/13/1994 | WO1994022471A1 Liquid antithrombin iii preparation and method of stabilizing the same |
10/13/1994 | WO1994022470A1 Factor xiii for treatment of skin wounds |
10/13/1994 | WO1994022469A1 Enhancement of learning and/or memory by a human somatotropin |
10/13/1994 | WO1994022468A1 Method for delivering beneficial compositions to hair follicles |
10/13/1994 | WO1994022467A1 Analogs of peptide yy and uses thereof |
10/13/1994 | WO1994022466A1 Methods of using insulin-like growth factor binding proteins |
10/13/1994 | WO1994022465A1 Method for reducing the viscosity of pathological mucoid airway contents in the respiratoy tract |
10/13/1994 | WO1994022464A1 Urokinase plasminogen activator fragments |
10/13/1994 | WO1994022463A1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d |
10/13/1994 | WO1994022462A1 Anti-aids immunomodulator complex |
10/13/1994 | WO1994022461A1 Formulation for nasal insulin delivery |
10/13/1994 | WO1994022460A1 Diagnosis and treatment of erectile dysfunction |
10/13/1994 | WO1994022455A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor |
10/13/1994 | WO1994022451A1 Selective regulation of b lymphocyte precursors by hormones |
10/13/1994 | WO1994022439A1 Oral glutamine to reduce stomatitis |
10/13/1994 | WO1994022438A1 Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation |
10/13/1994 | WO1994022437A2 Method for treating amyloidosis |
10/13/1994 | WO1994022427A1 Method for preparing drugs to treat dermal disorders |
10/13/1994 | WO1994022309A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
10/13/1994 | WO1994022306A1 Nitric oxide combination therapy |
10/13/1994 | WO1994021240A3 Superparamagnetic particles, process for producing the same and their use |
10/13/1994 | WO1994020063A3 Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
10/13/1994 | WO1994018332A3 Anthrax toxin fusion proteins and uses thereof |
10/13/1994 | WO1994017828A3 Treatment for insulin dependent diabetes |
10/13/1994 | WO1994017189A3 Protein kinases |
10/13/1994 | WO1994012635A3 Novel seven transmembrane receptors |
10/13/1994 | DE4312913A1 Oxytocin, vasopressin and alpha beta gamma -endorphin medicament composition |
10/13/1994 | DE4311756A1 Modified peptides, pharmaceutical compositions containing these compounds, and processes for their production |
10/13/1994 | CA2164123A1 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
10/13/1994 | CA2160154A1 Methods of using insulin-like growth factor binding proteins |
10/13/1994 | CA2160139A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
10/13/1994 | CA2160011A1 Chimeric cytokine receptors in lymphocytes |
10/13/1994 | CA2159898A1 Hybrid genes for use in the production of t h-independent cytotoxic t cells |
10/13/1994 | CA2159717A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor |
10/13/1994 | CA2159639A1 Method for selective inactivation of viral replication |
10/13/1994 | CA2159637A1 Urokinase plasminogen activator fragments |
10/13/1994 | CA2159595A1 Suppressor of hiv replication and transcription |
10/13/1994 | CA2159506A1 Inhibitor of stem cell proliferation and uses thereof |
10/13/1994 | CA2159499A1 Biologically active polypeptide fusion dimers |
10/13/1994 | CA2159498A1 Method for preparing drugs to treat dermal disorders |
10/13/1994 | CA2159445A1 Radiolabeled platelet gpiib/iiia receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
10/13/1994 | CA2159314A1 An .alpha.-galactosidase enzyme |
10/13/1994 | CA2159313A1 Purification of factor vii |
10/13/1994 | CA2159205A1 Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract |
10/13/1994 | CA2159116A1 Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation |
10/13/1994 | CA2159072A1 Novel processes and intermediate compounds for the preparation of platelet glycoprotein iib/iiia inhibitors |
10/13/1994 | CA2159070A1 Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia |
10/13/1994 | CA2158554A1 Pharmaceuticals based on papillomaviruses |
10/13/1994 | CA2158540A1 Cloned leptospira outer membrane protein |
10/13/1994 | CA2158171A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
10/13/1994 | CA2157766A1 Analogs of peptide yy and uses thereof |
10/13/1994 | CA2156641A1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use |
10/13/1994 | CA2156619A1 Chelators agents of the type xn1s1x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses |
10/13/1994 | CA2156618A1 Bifunctional chelators and their use in radiopharmaceuticals |
10/13/1994 | CA2137258A1 Liquid preparation of antithrombin-iii and stabilizing method therefor |
10/13/1994 | CA2136973A1 Recombinant timothy grass pollen allergen ph1 pii |
10/12/1994 | EP0619372A1 Tumor necrosis factor muteins |
10/12/1994 | EP0619371A1 Polypeptide derived from a glioblastoma cell line, its use and DNAs encoding it |
10/12/1994 | EP0619370A1 Keratinocyte growth factor (KGF) for its use in method of therapeutic treatment for the human or animal body |
10/12/1994 | EP0619324A1 HUMAN TYPE ANTIBODY REACTIVE WITH GPIIb/IIIa |
10/12/1994 | EP0619323A1 Human monoclonal antibodies and processes and materials for making such antibodies |
10/12/1994 | EP0619322A2 Prolonged delivery of peptides |
10/12/1994 | EP0619120A1 Use of human interferon-alpha for the manufacture of a medicament for treatment of respiratory disease in cats |
10/12/1994 | EP0619119A1 Stabilized parathyroid hormone composition |
10/12/1994 | EP0619118A1 Use of peptide derivatives |
10/12/1994 | EP0619115A1 Container comprising a metered dose valve and microparticles of a drug for topical treatment of skin disorders |
10/12/1994 | EP0618970A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
10/12/1994 | EP0618969A1 Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
10/12/1994 | EP0618968A1 Tools for the diagnosis and treatment of alzheimer's disease |
10/12/1994 | EP0618967A1 Ifn-gamma antagonist cytokine |
10/12/1994 | EP0618965A1 Method for generating structural and functional diversity in a peptide sequence |
10/12/1994 | EP0618964A1 Novel tissue plasminogen activator variants |
10/12/1994 | EP0618962A1 Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis |
10/12/1994 | EP0618929A1 Bispecific antibody heterodimers |
10/12/1994 | EP0618928A1 Pharmaceutical composition containing anti-allergenic antibodies, method of purifying said antibodies and antibodies thus obtained |
10/12/1994 | EP0618927A1 Cytokines with an unpaired cysteine residue and conjugates thereof |
10/12/1994 | EP0618926A1 New peptide derivatives |
10/12/1994 | EP0618925A1 Gapped 2' modified oligonucleotides |
10/12/1994 | EP0618923A1 Peptide nucleic acids and their effect on genetic material |
10/12/1994 | EP0618812A1 Use of protease nexin-i as an antiinflammatory |
10/12/1994 | EP0618811A1 Proteolytic mixture containing escharase and method of isolating same |